Safety and efficacy of linvoseltamab (LINVO) combined with anti-CD38 monoclonal antibodies (mAbs) daratumumab (DARA) or isatuximab (ISA) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Initial results from the multicohort, Phase 1b LINKER-MM2 trial


Por: Dimopoulos, M, Delimpasi, S, Manier, S, Michot, JM, Ocio, E, Rubinstein, S, Cook, J, Chamorro, MDM, Breazna, A, Dhadwal, A, Ghodke, Y, Masinde, S, Kroog, G, Sarkaria, S and Oriol, A

Publicada: 1 dic 2025 Ahead of Print: 1 dic 2025
Resumen:


Filiaciones:
Dimopoulos, M:
 Natl & Kapodistrian Univ Athens, Alexandra Gen Hosp, Athens, Greece

Delimpasi, S:
 Evangelismos Gen Hosp, Dept Haematol & Bone Marrow Transplantat Unit, Athens, Greece

Manier, S:
 Lille Univ Hosp, Hematol Dept, Lille, France

Michot, JM:
 Gustave Roussy Canc Campus, Villejuif, France

Ocio, E:
 Univ Cantabria Santander, Marques de Valdecilla Univ Hosp IDIVAL, Serv Hematol & Hemoterapia, Hosp Univ, Santander, Spain

Rubinstein, S:
 Univ North Carolina, Dept Hematol Oncol, Chapel Hill, NC USA

Cook, J:
 Mayo Clin, Rochester, NY USA

Chamorro, MDM:
 Hosp Univ Quironsalud Madrid, Hematol Dept, Madrid, Spain

 Univ Europea Madrid, Madrid, Spain

Breazna, A:
 Regeneron Pharmaceut Inc, Tarrytown, NY USA

Dhadwal, A:
 Regeneron Pharmaceut Inc, Tarrytown, NY USA

Ghodke, Y:
 Regeneron Pharmaceut Inc, Tarrytown, NY USA

Masinde, S:
 Regeneron Pharmaceut Inc, Tarrytown, NY USA

Kroog, G:
 Regeneron Pharmaceut Inc, Tarrytown, NY USA

Sarkaria, S:
 Regeneron Pharmaceut Inc, Tarrytown, NY USA

:
 Inst Catala Oncol, Dept Hematol, Badalona, Spain

 Inst Josep Carreras Hosp Germans Trias i Pujol, Badalona, Spain
ISSN: 00064971





Blood
Editorial
American Society of Hematology, 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 146 Número:
Páginas: 2254-2255
WOS Id: 001660396400004
imagen Bronze

MÉTRICAS